Skip to main content
. 2021 Apr 22;2021(4):CD013170. doi: 10.1002/14651858.CD013170.pub2

4. Study results grouped by outcome measures and interventions – cough augmentation therapy compared to standard care.

Outcome measure Study identifier
Sample size
Data presentation
Unassisted cough Manual BS Standard care Between‐group differences
Number and duration of unscheduled hospital and ICU admissions Katz 2019
n = 67
Units not specified
Not reported Not reported No results reported
Unassisted PCF Katz 2019
n = 67
Units not specified
Not reported Not reported No results reported
Health‐related quality of life Katz 2019
n = 67
Pediatric Quality of Life Inventory score
Not reported Not reported No results reported
FVC Katz 2019
n = 67
Median
% predicted
85.5 (entire cohort)a 4.1% change 6.4% change Adjusted MD 2.0, 95% CI –8.2 to 12.3
Time to 10% decline in FVC Katz 2019
n = 67
Not reported
Data not reported Data not reported Manual BS vs standard care: P = 0.5
Maximal inspiratory or insufflation capacity Katz 2019
n = 67
Units not specified
Not reported Not reported No results reported
MEP Katz 2019
n = 67
Units not specified
Not reported Not reported No results reported
MIP Katz 2019
n = 67
Units not specified
Not reported Not reported No results reported
Number and duration of outpatient oral antibiotic courses Katz 2019
n = 67
Units not specified
Not reported Not reported No results reported

BS: breathstacking; CI: confidence interval; FVC: forced vital capacity; ICU: intensive care unit; MD: mean difference; MEP: maximal expiratory pressure; MIP: maximal inspiratory pressure; n: number of participants; PCF: peak cough flow.

aBaseline value – not a randomly assigned control